Imagion Biosystems today announced “Notice of change of interests of substantial holder — IBX.”
View Form 604 Notice of change of interests of substantial holder — IBX.
Dr. Nina Webster Joins IBX Board of Directors
September 1, 2025
Imagion Biosystems (ASX: IBX) (Company or Imagion), a company dedicated to improving healthcare outcomes through the early detection of cancer utilizing its proprietary MagSense® imaging